Clinical Trial Update: C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study. [NA]

View source ↗

Summary

Enrollment is ongoing by invitation for a dose de-escalation study of the C2 CryoBalloon 180 Ablation System in Barrett Esophagus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Drugs mentioned

• C2 CryoBalloon 180 Ablation System

Snippet

Sponsor: Pentax Medical | Conditions: Barrett Esophagus | NA | Status: ENROLLING_BY_INVITATION